Soltis Investment Advisors LLC - INTERCEPT PHARMACEUTICALS IN ownership

Back to all holdings Add to watchlist

INTERCEPT PHARMACEUTICALS IN's ticker is and the CUSIP is 45845PAA6. A total of 24 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Links
Filings
Quarter-by-quarter ownership
Soltis Investment Advisors LLC ownership history of INTERCEPT PHARMACEUTICALS IN
ValueSharesWeighting
Q4 2021$9,0000.0%10,0000.0%0.00%0.0%
Q3 2021$9,0000.0%10,0000.0%0.00%0.0%
Q2 2021$9,000
+12.5%
10,0000.0%0.00%0.0%
Q1 2021$8,000–10,000–0.00%–
 Download
Other shareholders

There were no reported owners of INTERCEPT PHARMACEUTICALS IN in Q1 2022.

NameSharesValueWeighting ↓
View complete list of INTERCEPT PHARMACEUTICALS IN shareholders